Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Osteoporosis International
Published in: Osteoporosis International 4/2008

Open Access 01-04-2008 | Editorial

Assessment of 10-year absolute fracture risk: a new paradigm with worldwide application

Authors: E. Siris, P. D. Delmas

Published in: Osteoporosis International | Issue 4/2008

Login to get access

Excerpt

In this issue of Osteoporosis International we present several papers representing common approaches to the evaluation of fracture risk [1‐5]. This represents a considerable change for the field, moving from descriptions of risk as “relative risk,” as occurs on the output of DXA equipment, to what might be called “absolute risk” or “real risk,” neither of which is an adequate description. The model allows an assessment of the likelihood of hip or major osteoporosis-related fracture within a specific time frame (10 years) for individual patients. …
Literature
1.
Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAXTM and the assessment of fracture probability in men and women from the UK. Osteoporos Int DOI 10.​1007/​s00198-007-0543-5
2.
Fujiwara S, Nakamura T, Orimo H, Hosoi T, Gorai I, Oden A, Johansson H, Kanis JA (2008) Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAXTM). Osteoporos Int DOI 10.​1007/​s00198-007-0544-4
3.
Tosteson ANA, Melton III LJ, Dawson-Hughes B, Baim S, Favus MJ, Khosla S, Lindsay RL (2008) Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int DOI 10.​1007/​s00198-007-0550-6
4.
Dawson-Hughes B, Tosteson ANA, Melton III LJ, Baim S, Favus MJ, Khosla S, Lindsay RL (2008) Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int DOI 10.​1007/​s00198-008-0559-5
5.
Leslie WD for the Manitoba Bone Density Program (2008) Absolute fracture risk reporting in clinical practice: a physician-centered survey. Osteoporos Int DOI 10.​1007/​s00198-008-0565-7
6.
Kanis JA, Burlet N, Cooper C, et al. (2008) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int DOI 10.​1007/​s00198-008-0560-z
Metadata
Title
Assessment of 10-year absolute fracture risk: a new paradigm with worldwide application
Authors
E. Siris
P. D. Delmas
Publication date
01-04-2008
Publisher
Springer-Verlag
Published in
Osteoporosis International / Issue 4/2008
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-008-0564-8

Other articles of this Issue 4/2008

Osteoporosis International 4/2008 Go to the issue

Original Article

Effect of prior and ongoing raloxifene therapy on response to PTH and maintenance of BMD after PTH therapy

Special Position Paper

Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX™)

Review

Salmon calcitonin: a review of current and future therapeutic indications

Special Position Paper

Cost-effective osteoporosis treatment thresholds: the United States perspective

Original Article

Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis

Original Article

Experimental hip fracture load can be predicted from plain radiography by combined analysis of trabecular bone structure and bone geometry